FOR IMMEDIATE RELEASE
WASHINGTON, D.C., August 1, 2025 – AIDS United’s Harm Reduction team is requesting submissions for their 16th grant cycle. The Harm Reduction Futures Fund (HRFF) is a collaborative grantmaking initiative that seeks to reduce the health, psychosocial, and socioeconomic disparities experienced by people who use drugs (PWUD).
For over 20 years,HRFF has invested in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts, and connect people who use drugs to comprehensive prevention, treatment, and support services.
In Round 16, HRFF seeks to identify and support organizations across intersecting movements to enhance and coordinate services for people who use drugs. It supports and funds organizations that are led by and/or meaningfully involve and serve networks of people who use drugs, including in the design, delivery, and evaluation of services. This includes syringe services programs providing direct services and harm reduction organizations supporting multiple syringe. service programs providing direct services.
In Round 16, HRFF seeks to award seven to fifteen (7-15) cash grants under two categories:
- Direct Service organizations are invited to submit proposals for $10,000 to $25,000 for one year. (AU anticipates 5-13 programs will receive funding)
- Multi-program support organizations are invited to submit proposals for $25,000 to $40,000 for one year. (AU anticipates 1 program will receive funding)
The application process for Round 16 requires the completion of the pre-application survey, via AIDS United’s online application portal. Submissions are due by 5:00 p.m. ET on August 21, 2025. A community-based review committee will evaluate all pre-application survey submissions and invite up to forty (40) applicants to submit a full proposal.
- Click here to read or download the full guidance for the HRFF Round 16 Grant Cycle: Request for Pre-Application Survey.
- Click here to apply for HRFF Round 16 grant cycle.
For key dates and deadlines, see below:
| August 1, 2025 | Request for Pre-Application Surveys Released |
| August 8, 2025 | Pre-Application Survey TA Webinar at 1:00pm EST |
| August 21, 2025` | Pre-Application Survey Due at 5:00 p.m. EST |
| September 19, 2025 | Notification of Full Proposal Invitation Decisions |
| September 29, 2025 | Request for Proposals TA Webinar |
| October 20, 2025 | Full Proposals Due at 5:00pm EST |
| December 18, 2025 | Notification of Funding Decisions |
| February 1, 2026 | Grant Period Begins |
| September 1, 2026 | Interim Report Due |
| January 31, 2027 | Grant Period Ends |
| March 1, 2027 | Final Report Due |
Technical Assistance & Application Support
- Technical Assistance Webinar: A webinar will be held Friday, August 8, 1-2pm ET to provide clarification about the grant announcement and key application submission tips. Click here to register for the webinar.
- Optional one-on-one technical assistance: Optional one-on-one technical assistance office hours will be offered by staff August 6 through August 20, 2025 in 15 minute time slots. Click here to sign up for office hours
- If you have any questions about this funding opportunity or the content of your pre-application survey, please reach out to Angelo Gomez, Senior Program Manager for Harm Reduction Futures Fund at harmreduction@aidsunited.org. If you have any questions about navigating our online application form or submitting your survey, please contact grants@aidsunited.org
About Harm Reduction Futures Fund: The Harm Reduction Futures Fund strengthens the lifesaving work of syringe services programs nationwide. Its mission remains the same as it was nearly two decades ago: to reduce the health, psychosocial and socioeconomic disparities experienced by people who use drugs. To that end, the fund invests in evidence-based and community-driven approaches to prevent the transmission of both HIV and viral hepatitis, reduce injection-related injuries, increase overdose prevention and reversal efforts and connect people who use drugs to comprehensive prevention, treatment, and support services.